Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9AP85
Term | Name | Level | Count |
---|---|---|---|
GO:0006040 | amino sugar metabolic process | 4 | 7 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 4 | 7 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5 | 7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009225 | nucleotide-sugar metabolic process | 4 | 7 |
GO:0009226 | nucleotide-sugar biosynthetic process | 5 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0044281 | small molecule metabolic process | 2 | 7 |
GO:0046349 | amino sugar biosynthetic process | 5 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 7 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004343 | glucosamine 6-phosphate N-acetyltransferase activity | 7 | 7 |
GO:0008080 | N-acetyltransferase activity | 6 | 7 |
GO:0016407 | acetyltransferase activity | 5 | 7 |
GO:0016410 | N-acyltransferase activity | 5 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016746 | acyltransferase activity | 3 | 7 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.353 |
CLV_PCSK_FUR_1 | 175 | 179 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.353 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.426 |
DOC_CYCLIN_yCln2_LP_2 | 252 | 258 | PF00134 | 0.278 |
DOC_MAPK_gen_1 | 244 | 252 | PF00069 | 0.389 |
DOC_MAPK_MEF2A_6 | 247 | 254 | PF00069 | 0.282 |
DOC_MAPK_NFAT4_5 | 247 | 255 | PF00069 | 0.294 |
DOC_PP1_RVXF_1 | 218 | 224 | PF00149 | 0.214 |
DOC_PP2B_LxvP_1 | 252 | 255 | PF13499 | 0.358 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.373 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.214 |
DOC_USP7_UBL2_3 | 38 | 42 | PF12436 | 0.417 |
DOC_WW_Pin1_4 | 239 | 244 | PF00397 | 0.415 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.241 |
LIG_14-3-3_CanoR_1 | 222 | 230 | PF00244 | 0.389 |
LIG_Actin_WH2_2 | 104 | 121 | PF00022 | 0.424 |
LIG_APCC_ABBA_1 | 70 | 75 | PF00400 | 0.497 |
LIG_APCC_ABBAyCdc20_2 | 69 | 75 | PF00400 | 0.411 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.601 |
LIG_BRCT_BRCA1_1 | 231 | 235 | PF00533 | 0.453 |
LIG_EH_1 | 150 | 154 | PF12763 | 0.481 |
LIG_eIF4E_1 | 163 | 169 | PF01652 | 0.451 |
LIG_eIF4E_1 | 98 | 104 | PF01652 | 0.373 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.294 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.366 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.403 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.430 |
LIG_GBD_Chelix_1 | 95 | 103 | PF00786 | 0.420 |
LIG_HP1_1 | 255 | 259 | PF01393 | 0.278 |
LIG_LIR_Gen_1 | 22 | 31 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 46 | 55 | PF02991 | 0.601 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.513 |
LIG_Pex14_2 | 219 | 223 | PF04695 | 0.453 |
LIG_SH2_GRB2like | 98 | 101 | PF00017 | 0.340 |
LIG_SH2_NCK_1 | 236 | 240 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 101 | 105 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.246 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.364 |
LIG_SH3_4 | 38 | 45 | PF00018 | 0.406 |
LIG_SxIP_EBH_1 | 162 | 175 | PF03271 | 0.488 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.511 |
LIG_WRC_WIRS_1 | 48 | 53 | PF05994 | 0.293 |
MOD_CDK_SPK_2 | 239 | 244 | PF00069 | 0.389 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.453 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.339 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.513 |
MOD_GlcNHglycan | 124 | 128 | PF01048 | 0.485 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.310 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.422 |
MOD_N-GLC_1 | 9 | 14 | PF02516 | 0.498 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.317 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.720 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.595 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.497 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.509 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.326 |
MOD_NEK2_2 | 170 | 175 | PF00069 | 0.275 |
MOD_PKA_1 | 177 | 183 | PF00069 | 0.453 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.453 |
MOD_PKB_1 | 175 | 183 | PF00069 | 0.453 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.318 |
MOD_Plk_4 | 164 | 170 | PF00069 | 0.514 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.336 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.329 |
MOD_ProDKin_1 | 239 | 245 | PF00069 | 0.415 |
MOD_SUMO_rev_2 | 106 | 111 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 53 | 61 | PF00179 | 0.404 |
TRG_DiLeu_BaEn_1 | 107 | 112 | PF01217 | 0.410 |
TRG_DiLeu_BaEn_1 | 30 | 35 | PF01217 | 0.405 |
TRG_DiLeu_BaEn_4 | 83 | 89 | PF01217 | 0.380 |
TRG_DiLeu_BaLyEn_6 | 113 | 118 | PF01217 | 0.440 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.388 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.214 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.426 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.350 |
TRG_ER_diArg_1 | 219 | 222 | PF00400 | 0.214 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.503 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6B9 | Leptomonas seymouri | 52% | 99% |
A0A3S7WSF7 | Leishmania donovani | 81% | 98% |
A4H750 | Leishmania braziliensis | 66% | 100% |
A4HVJ0 | Leishmania infantum | 81% | 98% |
Q4QG93 | Leishmania major | 82% | 100% |